mefloquine has been researched along with fanasil, pyrimethamine drug combination in 102 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 26 (25.49) | 18.7374 |
1990's | 19 (18.63) | 18.2507 |
2000's | 27 (26.47) | 29.6817 |
2010's | 29 (28.43) | 24.3611 |
2020's | 1 (0.98) | 2.80 |
Authors | Studies |
---|---|
Ghosh, SK; Sharma, VP; Yadav, RS | 1 |
Bunnag, D; Chindanond, D; Chittamas, S; Fernex, M; Harinasuta, T; Kristiansen, S; Malikul, S; Mittelholzer, ML; Sturchler, D | 1 |
Adio, RA; Dickschat, U; Mittelholzer, ML; Reber-Liske, R; Salako, LA; Sowunmi, A; Stürchler, D; Walker, O | 1 |
Salako, LA; Sowunmi, A | 1 |
Carme, B | 1 |
Baird, JK; Bangs, MJ; Basri, H; Jones, TR; Ritonga, A | 1 |
Boudreau, EF; Chaikummao, S; Pang, LW; Witayarut, C | 1 |
Holdener, F; Nurminen, L; Steffen, R; Wyss, R | 1 |
Hall, AP; Malin, AS | 1 |
Eberlé, F; Gazin, P; Gelas, H; Hengy, C; Jambou, R; Kouka-Bemba, D | 1 |
Newbold, CI; Pasvol, G; Peto, TE | 1 |
Arnold, K | 1 |
Bunnag, D; Harinasuta, T; Lasserre, R; Leimer, R; Vinijanont, S | 1 |
Campbell, JR; Dimpudus, AJ; Harun, S; Heizmann, P; Hoffman, SL; Marwoto, HA; Oetomo, HS; Punjabi, NH; Rustama, D; Sukri, N | 1 |
Druilhe, P; Gentilini, M; Stahel, E | 1 |
Fernex, M | 2 |
Beeching, NJ; Eales, M; Ellis-Pegler, RB; Fraser, AG; Wells, AU | 1 |
Rolfe, M | 1 |
Burchard, GD; Winkler, E | 1 |
Ekue, JM; Mukunyandela, M; Phiri, DE; Sheth, UK | 1 |
Charmot, G; Le Bras, J; Simon, F | 1 |
Dubach, VC; Forgo, I; Ranalder, VB; Schwartz, DE; Weber, B; Weidekamm, E | 1 |
Bhattacharya, DN; Hall, AP | 1 |
Dubach, UC; Schwartz, DE; Weber, B; Weidekamm, E | 1 |
Glasner, H; Landscheidt, H; Niklewski, G | 1 |
Arias, AE; Cortes, GT; Espinal, CA; Guerra, P | 1 |
de Oliveira, RM; de Souza, JM; de Souza, SD; Roulet, H; Sheth, UK | 1 |
Cavalcante, EQ; de Oliveira, RM; de Souza, JM; Gomes, AT; Sheth, UK | 1 |
Botero, D; Montoya, A; Restrepo, M | 1 |
Danis, M; Gentilini, M | 1 |
Arnold, K; Fu, LC; Guo, XB; Jian, HX; Li, GQ | 1 |
Ferraroni, JJ; Genaro, O | 1 |
Dixon, KE; Phintuyothin, P; Pitaktong, U; Pongsupat, T; Williams, RG | 1 |
Ranalder, UB; Schwartz, DE | 1 |
Timm, U; Weidekamm, E | 1 |
Deacon, HE; Freese, JA; Sharp, BL | 1 |
Chatnugrob, P; Eamsila, C; Lasserre, R; Mittelholzer, ML; Nopavong Na Ayuthya, A; Singharaj, P; Stürchler, D; Webster, HK; Yooyen, P | 1 |
Yang, H; Yang, P; Yang, Y | 1 |
Angel, VH; Friman, G; Hellgren, U; Mittelholzer, ML; Rombo, L; Stürchler, D | 1 |
Bálint, GS | 1 |
Edwards, R; Fuchs, E; Kerr, L; Phillips-Howard, PA; Schildknecht, J; Steffen, R; Vanhauwere, B | 1 |
Bourgeade, A; Delmont, J | 1 |
Makonnen, E; Mengesha, T | 1 |
Dalvi, SS; Gogtay, NJ; Kshirsagar, NA; Rajgor, D; Wakde, M | 1 |
Saul, A | 1 |
Ali, D; Barat, LM; Green, MD; Kazembe, PN; Kolczak, MS; MacArthur, J; Macheso, A; Ruebush, TK; Stennies, GM | 1 |
Bedos, JP; Bruneel, F; Danis, M; Gachot, B; Regnier, B; Vachon, F; Wolff, M | 1 |
Arróspide, N; Arrunátegui, M; Barat, LM; Cabezas, C; Carrillo, C; Chafloque, ML; Garavito, G; Gutierrez, S; MacArthur, JR; Marquiño, W; Oblitas, FE; Pardavé, B; Ruebush, TK | 1 |
Alkadru, AM; Awad, MI; Baraka, OZ; Behrens, RH; Eltayeb, IB | 1 |
Nakajima, Y | 1 |
Pfeifer, C; Strauss, R | 1 |
Fateye, BA; Sowunmi, A | 1 |
Fischer, PR; Stauffer, W | 1 |
Hoshen, M | 1 |
Annerberg, A; Barends, M; Keola, S; Khanthavong, M; Lindegårdh, N; Mayxay, M; Newton, PN; Phetsouvanh, R; Phompida, S; Pongvongsa, T; White, NJ; Yapom, R | 1 |
Kyaw, MK; Lwin, S; Savran, O; Shahmanesh, M; Smithuis, F; White, NJ | 1 |
Meshnick, SR; Prajakwong, S; Shanks, GD; Thimasarn, K; Wongsrichanalai, C | 1 |
Baird, JK | 1 |
Bangali, AM; Barends, M; Das, S; Faiz, AM; Kamal, M; Liem, L; Maung, UA; Peters, A; Rahman, M; Rahman, MR; van den Broek, IV | 1 |
Garner, P; Jones, K; Taylor-Robinson, D | 1 |
Kremsner, PG; Krishna, S; Lell, B; Ramharter, M; Uhlemann, AC | 1 |
Baruah, S; Campbell, P; Narain, K; Rogers, CC | 1 |
Adedeji, AA; Bamgboye, AE; Bolaji, OM; Fateye, BA; Gbotosho, GO; Happi, TC; Oduola, AM; Sowunmi, A | 1 |
Dieng, Y; Faye, B; Faye, O; Gaye, O; Ndiaye, D; Ndiaye, JL | 1 |
Aubouy, A; Bertin, G; Deloron, P; Fievet, N; Kinde-Gazard, D; Kiniffo, R; Kossou, H; Massougbodji, A; Sagbo, JC | 1 |
Bissagnene, E; Die-Kakou, H; Jansen, FH; Lesaffre, E; Penali, LK; Zattera, MJ | 1 |
Donegan, S; Garner, P; Olliaro, P; Sinclair, D; Zani, B | 1 |
Ayemonna, P; Bottero, J; Briand, V; Cordel, H; Cot, M; Fayomi, B; Fievet, N; Guerra, J; Kossou, H; Masse, V; Massougbodji, A; Noël, H | 1 |
Cairns, M; Chandramohan, D; Gesase, S; Gosling, R; Greenwood, B; Mosha, J | 1 |
Carneiro, I; Chandramohan, D; Gesase, S; Gosling, RD; Greenwood, B; Hashim, R; Lemnge, M; Mosha, FW; Mosha, JF | 1 |
Cairns, M; Carneiro, I; Chandramohan, D; Gesase, S; Gosling, R; Greenwood, B; Hashim, R; Kaur, H; Lemnge, M; Mosha, FW; Mosha, JF | 1 |
Capan, M; Makristathis, A; Mombo-Ngoma, G; Ramharter, M | 1 |
Bouraima, A; Briand, V; Choudat, I; Cot, M; Cottrell, G; Dechavanne, C; Fayomi, B; Garcia, A; Guerra, J; Le Port, A; Massougbodji, A; Migot-Nabias, F | 1 |
Terlouw, DJ; van Eijk, AM | 1 |
Chandramohan, D; Chico, RM | 1 |
Bertin, G; Bonaventure, D; Briand, V; Carrieu, A; Cot, M; Deloron, P; Massougbodji, A | 1 |
Arango, EM; Carmona-Fonseca, J; Upegui, YA | 1 |
Bera, DK; Biswas, A; Chattopadhyay, G; Das, M; Das, S; Ganguly, S; Guha, SK; Kundu, PK; Maji, AK; Mullick, S; Ray, K; Saha, P | 1 |
Borgella, S; Briand, V; Cot, M; Deloron, P; Fievet, N; Huynh, BT; Massougbodji, A | 1 |
Al-Farsi, HM; Al-Hashami, ZS; Al-Qahtani, A; Al-Sheikh, AA; Babiker, HA; Bin Dajem, SM | 1 |
Garner, P; Gelband, H; Graves, PM | 3 |
Adegnika, AA; Basra, A; Diop, DA; Fürstenau, M; Gonzalez, R; Kremsner, PG; Mackanga, JR; Melser, MC; Menendez, C; Mombo-Ngoma, G; Ramharter, M; Würbel, H; Zoleko, RM | 1 |
Dondorp, AM; Faiz, MA; Hien, TT; Mokuolu, OA; Pukrittayakamee, S; White, NJ | 1 |
Aubouy, A; Dahlström, S; Deloron, P; Ezinmègnon, S; Faucher, JF; Houzé, P; Houzé, S; Kendjo, E; Le Bras, J; Maïga-Ascofaré, O; Massougbodji, A; Wakpo, A | 1 |
Adegnika, AA; Agnandji, ST; Akerey-Diop, D; Basra, A; Bélard, S; Capan-Melser, M; González, R; Groger, M; Kremsner, PG; Lötsch, F; Mackanga, JR; Matsiegui, PB; Menendez, C; Mombo Ngoma, G; Ramharter, M; Rehman, K; Schipulle, U; Schwing, J; Würbel, H; Zoleko-Manego, R | 1 |
Abdulla, S; Aponte, J; Cot, M; Desai, M; Fernandes, S; González, R; Hanson, K; Katana, A; Kremsner, P; Kuwawenaruwa, A; Macete, E; Massougbodgi, A; Menéndez, C; Mombo-Ngoma, G; Ramharter, M; Sicuri, E; Slustker, L | 1 |
Baker, M; Marquart, L; McCarthy, JS; O'Rourke, P | 1 |
Briand, V; Cot, M; Escolano, S; Journot, V; Massougbodji, A; Tubert-Bitter, P | 1 |
Alifrangis, M; Baraka, V; Carneiro, I; Chandramohan, D; Gesase, S; Gosling, R; Hashim, R; Ishengoma, D; Mosha, J; Poirot, E; Vittinghoff, E | 1 |
Abdulla, S; Accrombessi, M; Adegnika, AA; Aponte, JJ; Briand, V; Cot, M; González, R; Kabanywanyi, AM; Kakolwa, MA; Kremsner, PG; Macete, E; Manego Zoleko, R; Massougbodji, A; Menéndez, C; Mombo-Ngoma, G; Ouédraogo, S; Ramharter, M; Rupérez, M; Sevene, E; Vala, A | 1 |
Liu, XJ; Peng, HJ; Wei, HX; Xia, J; Zhou, LJ | 1 |
Lee, SJ; Luxemburger, C; Nosten, F; Price, RN; Ter Kuile, FO | 1 |
Duffy, PE; Fried, M | 1 |
Aponte, JJ; González, R; Menéndez, C; Piqueras, M; Pons-Duran, C; Ter Kuile, FO | 2 |
Abdus-Salam, R; Akinyotu, O; Arowojolu, A; Bello, F | 1 |
Akerey-Diop, D; Basra, A; Geditz, M; Gonzalez, R; Hofmann, U; Kerb, R; Kremsner, PG; Lehr, T; Mackanga, JR; Matsiegui, PB; Menendez, C; Mombo-Ngoma, G; Ramharter, M; Schwab, M; Wojtyniak, JG; Würbel, H; Zoleko Manego, R | 1 |
Aponte, JJ; Cisteró, P; Cot, M; Desai, M; González, R; Gupta, H; Huijben, S; Kariuki, S; Macete, E; Massougbodji, A; Mayor, A; Menéndez, C; Mombo-Ngoma, G; Mwangoka, G; Ndam, NT; Ramharter, M; Shi, YP; Uberegui, E | 1 |
18 review(s) available for mefloquine and fanasil, pyrimethamine drug combination
Article | Year |
---|---|
[Malaria in Switzerland].
Topics: Animals; Antimalarials; Drug Combinations; Drug Resistance; Humans; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine; Switzerland | 1988 |
[Urgent need for new antimalarias (author's transl)].
Topics: Antimalarials; Biological Availability; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Humans; Immunotherapy; Mefloquine; Piperidines; Pyrimethamine; Quinolines; Sulfadoxine; World Health Organization | 1981 |
Comparative efficacy and safety of chloroquine and alternative antimalarial drugs: a meta-analysis from six African countries.
Topics: Africa, Eastern; Africa, Western; Amodiaquine; Antimalarials; Chloroquine; Drug Combinations; Drug Costs; Humans; Malaria; Mefloquine; Patient Selection; Phenanthrenes; Pyrimethamine; Quinine; Safety; Sulfadoxine; Treatment Outcome | 1999 |
[Antiprotozoal drugs].
Topics: Animals; Antiprotozoal Agents; Drug Combinations; Emetine; Humans; Mefloquine; Metronidazole; Phenanthrenes; Primaquine; Protozoan Infections; Pyrimethamine; Quinine; Sulfadoxine; Tinidazole | 2003 |
Effectiveness of antimalarial drugs.
Topics: Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Life Cycle Stages; Malaria; Mefloquine; Patient Compliance; Plasmodium; Primaquine; Pyrimethamine; Quinine; Secondary Prevention; Sulfadoxine; Treatment Failure | 2005 |
Malaria: uncomplicated, caused by Plasmodium falciparum.
Topics: Amodiaquine; Antimalarials; Artemether; Artemisinins; Artesunate; Chloroquine; Dapsone; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria, Falciparum; Mefloquine; Proguanil; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2005 |
Assessment of the relative advantage of various artesunate-based combination therapies by a multi-treatment Bayesian random-effects meta-analysis.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Bayes Theorem; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Malaria; Mefloquine; Pyrimethamine; Randomized Controlled Trials as Topic; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2007 |
Artemisinin-based combination therapy for treating uncomplicated malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Fluorenes; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Parasitemia; Pyrimethamine; Quinolines; Randomized Controlled Trials as Topic; Sulfadoxine | 2009 |
Azithromycin for treating uncomplicated malaria.
Topics: Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Atovaquone; Azithromycin; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Proguanil; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine; Treatment Failure | 2011 |
Intermittent preventive treatment of malaria in pregnancy: at the crossroads of public health policy.
Topics: Adult; Africa South of the Sahara; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antimalarials; Azithromycin; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Care; Public Health; Pyrimethamine; Sexually Transmitted Diseases; Sulfadoxine; Treatment Outcome | 2011 |
Primaquine for reducing Plasmodium falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2012 |
Malaria.
Topics: Africa South of the Sahara; Amodiaquine; Animals; Anopheles; Antimalarials; Artemisinins; Artesunate; Asia, Southeastern; Chloroquine; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Insecticide-Treated Bednets; Insecticides; Malaria; Malaria Vaccines; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Pregnancy; Pregnancy Complications, Infectious; Primary Prevention; Pyrimethamine; Quinine; Quinolines; Seasons; Sulfadoxine | 2014 |
Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2014 |
Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.
Topics: Antimalarials; Artemisinins; Artesunate; Chloroquine; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinine; Randomized Controlled Trials as Topic; Sulfadoxine | 2015 |
Risk of drug resistance in Plasmodium falciparum malaria therapy-a systematic review and meta-analysis.
Topics: Amodiaquine; Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Risk; Sulfadoxine | 2017 |
Malaria during Pregnancy.
Topics: Africa; Antimalarials; Artemisinins; Drug Combinations; Drug Resistance; Female; Humans; Malaria; Malaria Vaccines; Mefloquine; Placenta; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Sulfadoxine | 2017 |
Mefloquine for preventing malaria in pregnant women.
Topics: Abortion, Spontaneous; Africa South of the Sahara; Antimalarials; Dizziness; Drug Combinations; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant, Low Birth Weight; Insecticide-Treated Bednets; Malaria; Mefloquine; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Randomized Controlled Trials as Topic; Sulfadoxine; Thailand; Trimethoprim, Sulfamethoxazole Drug Combination; Vomiting | 2018 |
Mefloquine for preventing malaria in pregnant women.
Topics: Anemia; Antimalarials; Drug Combinations; Drug Therapy, Combination; Female; HIV Seronegativity; Humans; Malaria; Mefloquine; Parasitemia; Placenta Diseases; Pregnancy; Pregnancy Complications; Pregnancy Complications, Infectious; Pyrimethamine; Randomized Controlled Trials as Topic; Stillbirth; Sulfadoxine; Trimethoprim, Sulfamethoxazole Drug Combination; Vomiting | 2018 |
39 trial(s) available for mefloquine and fanasil, pyrimethamine drug combination
Article | Year |
---|---|
Fansimef for prophylaxis of malaria: a double-blind randomized placebo controlled trial.
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Double-Blind Method; Drug Combinations; Humans; Incidence; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Pyrimethamine; Sulfadoxine; Treatment Outcome | 1992 |
Mefloquine-sulphadoxine-pyrimethamine (Fansimef, Roche) in the prophylaxis of Plasmodium falciparum malaria: a double-blind, comparative, placebo-controlled study.
Topics: Adolescent; Adult; Antimalarials; Chloroquine; Double-Blind Method; Drug Combinations; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Pyrimethamine; Sulfadoxine | 1992 |
Evaluation of the relative efficacy of various antimalarial drugs in Nigerian children under five years of age suffering from acute uncomplicated falciparum malaria.
Topics: Acute Disease; Amodiaquine; Antimalarials; Child, Preschool; Chloroquine; Drug Administration Schedule; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Male; Mefloquine; Nigeria; Pyrimethamine; Quinine; Sulfadoxine | 1992 |
Comparison of mefloquine, chloroquine plus pyrimethamine-sulfadoxine (Fansidar), and chloroquine as malarial prophylaxis in eastern Thailand.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Animals; Antimalarials; Cambodia; Chloroquine; Confidence Intervals; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Middle Aged; Pyrimethamine; Sulfadoxine; Survival Analysis; Thailand | 1991 |
Trials of mefloquine in vivax and of mefloquine plus 'fansidar' in falciparum malaria.
Topics: Adolescent; Adult; Chloroquine; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Follow-Up Studies; Humans; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Quinolines; Random Allocation; Sulfadoxine; Sulfanilamides | 1985 |
RII and RIII type resistance of Plasmodium falciparum to combination of mefloquine and sulfadoxine/pyrimethamine in Indonesia.
Topics: Adolescent; Adult; Antimalarials; Child; Clinical Trials as Topic; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Indonesia; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Random Allocation; Sulfadoxine; Sulfanilamides | 1985 |
A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria.
Topics: Administration, Oral; Adolescent; Adult; Animals; Antimalarials; Child; Double-Blind Method; Drug Combinations; Humans; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinolines; Random Allocation; Sulfadoxine; Sulfanilamides | 1987 |
An open, randomized, phase III clinical trial of mefloquine and of quinine plus sulfadoxine-pyrimethamine in the treatment of symptomatic falciparum malaria in Brazil.
Topics: Adolescent; Adult; Brazil; Clinical Trials as Topic; Drug Combinations; Humans; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Random Allocation; Sulfadoxine; Sulfanilamides | 1985 |
A phase I clinical trial of Fansimef (mefloquine plus sulfadoxine-pyrimethamine) in Brazilian male subjects.
Topics: Adult; Brazil; Double-Blind Method; Drug Combinations; Drug Evaluation; Humans; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Random Allocation; Sulfadoxine; Sulfanilamides | 1985 |
Prospective double-blind trial of two different doses of mefloquine plus pyrimethamine-sulfadoxine compared with pyrimethamine-sulfadoxine alone in the treatment of falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Clinical Trials as Topic; Colombia; Double-Blind Method; Drug Combinations; Drug Resistance, Microbial; Humans; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1985 |
Randomised comparative study of mefloquine, qinghaosu, and pyrimethamine-sulfadoxine in patients with falciparum malaria.
Topics: Adolescent; Adult; Antimalarials; Artemisinins; Child; China; Clinical Trials as Topic; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Prospective Studies; Pyrimethamine; Quinolines; Random Allocation; Sesquiterpenes; Sulfadoxine; Sulfanilamides | 1984 |
A comparative trial of Mefloquine and Fansidar in the treatment of falciparum malaria: failure of Fansidar.
Topics: Antimalarials; Drug Combinations; Drug Resistance, Microbial; Humans; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1982 |
Prevention of Plasmodium falciparum malaria by Fansimef and Lariam in the northeastern part of Thailand.
Topics: Adult; Animals; Antibodies, Protozoan; Blood; Chloroquine; Drug Combinations; Humans; Malaria, Falciparum; Male; Mefloquine; Military Personnel; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Thailand | 1993 |
Comparative tolerability and kinetics during long-term intake of Lariam and Fansidar for malaria prophylaxis in nonimmune volunteers.
Topics: Adult; Antimalarials; Double-Blind Method; Drug Combinations; Half-Life; Humans; Linear Models; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Patient Dropouts; Pyrimethamine; Sulfadoxine | 1993 |
Efficacy of mefloquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum infection in Machinga District, Malawi, 1998.
Topics: Animals; Antimalarials; Child, Preschool; Disease-Free Survival; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Malawi; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2001 |
Efficacy of chloroquine, sulfadoxine-pyrimethamine, and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria on the north coast of Peru.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Peru; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Treatment Outcome | 2003 |
Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
Topics: Adolescent; Adult; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Laos; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2004 |
Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
Topics: Adolescent; Adult; Age Distribution; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Hemoglobins; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Myanmar; Pyrimethamine; Recurrence; Sesquiterpenes; Sulfadoxine; Treatment Failure | 2004 |
Efficacy of chloroquine + sulfadoxine--pyrimethamine, mefloquine + artesunate and artemether + lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, Bangladesh.
Topics: Adolescent; Antimalarials; Artemether; Artemisinins; Artesunate; Bangladesh; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluorenes; Humans; Infant; Lumefantrine; Malaria, Falciparum; Male; Mefloquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2005 |
Amplification of Plasmodium falciparum multidrug resistance gene 1 in isolates from Gabon.
Topics: Adolescent; Animals; Antimalarials; ATP-Binding Cassette Transporters; Child; Child, Preschool; Double-Blind Method; Drug Combinations; Drug Resistance; Gabon; Genes, MDR; Humans; Infant; Infant, Newborn; Malaria, Falciparum; Mefloquine; Parasitic Sensitivity Tests; Plasmodium falciparum; Protozoan Proteins; Pyrimethamine; Sulfadoxine | 2005 |
A randomized trial comparing the efficacy of four treatment regimens for uncomplicated falciparum malaria in Assam state, India.
Topics: Adolescent; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Therapy, Combination; Female; Humans; India; Infant; Malaria, Falciparum; Male; Mefloquine; Prospective Studies; Pyrimethamine; Quinolines; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2006 |
Predictors of the failure of treatment with pyrimethamine-sulfadoxine in children with uncomplicated falciparum malaria.
Topics: Aging; Antimalarials; Artemether; Artemisinins; Child; Child, Preschool; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Nigeria; Predictive Value of Tests; Pyrimethamine; Risk Factors; Sulfadoxine; Time Factors; Treatment Failure | 2006 |
Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal.
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Artemether; Artemisinins; Artesunate; Child; Child, Preschool; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluorenes; Follow-Up Studies; Humans; Infant; Lumefantrine; Malaria, Falciparum; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Senegal; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2007 |
Dramatically decreased therapeutic efficacy of chloroquine and sulfadoxine-pyrimethamine, but not mefloquine, in southern Benin.
Topics: Administration, Oral; Animals; Antigens, Protozoan; Antimalarials; Benin; Child, Preschool; Chloroquine; DNA, Protozoan; Drug Combinations; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Merozoite Surface Protein 1; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2007 |
Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Antimalarials; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Single-Blind Method; Stillbirth; Sulfadoxine; Young Adult | 2009 |
Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
Topics: Antimalarials; Dapsone; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Resistance; Female; Follow-Up Studies; Half-Life; Humans; Immunization Schedule; Incidence; Infant; Infant Mortality; Logistic Models; Malaria, Falciparum; Male; Mefloquine; Multivariate Analysis; Proguanil; Pyrimethamine; Safety; Sulfadoxine; Tanzania; Treatment Outcome | 2009 |
Duration of protection against clinical malaria provided by three regimens of intermittent preventive treatment in Tanzanian infants.
Topics: Antimalarials; Dapsone; Drug Administration Schedule; Drug Combinations; Drug Resistance; Humans; Immunization Schedule; Infant; Infant, Newborn; Malaria; Mefloquine; Pediatrics; Placebos; Proguanil; Pyrimethamine; Research Design; Sulfadoxine; Tanzania; Time Factors; Treatment Outcome | 2010 |
Prevention of malaria during pregnancy: assessing the effect of the distribution of IPTp through the national policy in Benin.
Topics: Adult; Antimalarials; Benin; Chloroquine; Drug Combinations; Female; Health Policy; HIV Infections; Humans; Infant, Low Birth Weight; Infant, Newborn; Malaria; Maternal Age; Mefloquine; Multivariate Analysis; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Risk Factors; Sulfadoxine; Young Adult | 2011 |
Efficacy of different primaquine-based antimalarial regimens against Plasmodium falciparum gametocytemia.
Topics: Adolescent; Adult; Aged; Amodiaquine; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Colombia; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Germ Cells; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Parasitemia; Plasmodium falciparum; Primaquine; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2012 |
Comparative efficacies of artemisinin combination therapies in Plasmodium falciparum malaria and polymorphism of pfATPase6, pfcrt, pfdhfr, and pfdhps genes in tea gardens of Jalpaiguri District, India.
Topics: Adolescent; Adult; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Artesunate; Biomarkers; Calcium-Transporting ATPases; Child; Child, Preschool; Dihydropteroate Synthase; Drug Combinations; Ethanolamines; Female; Fluorenes; Follow-Up Studies; Humans; India; Malaria, Falciparum; Male; Mefloquine; Membrane Transport Proteins; Mutation; Plasmodium falciparum; Polymorphism, Genetic; Protozoan Proteins; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Treatment Outcome | 2012 |
Consequences of gestational malaria on birth weight: finding the best timeframe for intermittent preventive treatment administration.
Topics: Adolescent; Adult; Antimalarials; Birth Weight; Drug Combinations; Female; Humans; Infant, Newborn; Malaria; Mefloquine; Middle Aged; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Treatment Outcome; Young Adult | 2012 |
Efficacy of mefloquine intermittent preventive treatment in pregnancy against Schistosoma haematobium infection in Gabon: a nested randomized controlled assessor-blinded clinical trial.
Topics: Adult; Animals; Anthelmintics; Chemoprevention; Drug Combinations; Feces; Female; Gabon; Humans; Mefloquine; Parasite Egg Count; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Rural Population; Schistosoma haematobium; Schistosomiasis haematobia; Single-Blind Method; Sulfadoxine; Treatment Outcome; Young Adult | 2013 |
Economic evaluation of an alternative drug to sulfadoxine-pyrimethamine as intermittent preventive treatment of malaria in pregnancy.
Topics: Antimalarials; Cost-Benefit Analysis; Drug Combinations; Female; HIV Infections; Humans; Kenya; Malaria; Mefloquine; Mozambique; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Sulfadoxine; Tanzania; Treatment Outcome | 2015 |
Evaluating the pharmacodynamic effect of antimalarial drugs in clinical trials by quantitative PCR.
Topics: Adolescent; Adult; Algorithms; Antimalarials; Area Under Curve; Drug Combinations; Female; Half-Life; Humans; Malaria; Male; Mefloquine; Models, Statistical; Parasitemia; Polymerase Chain Reaction; Pyrimethamine; Reproducibility of Results; Sulfadoxine; Young Adult | 2015 |
Mefloquine Versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment in Pregnancy: A Joint Analysis on Efficacy and Tolerability.
Topics: Anemia; Antimalarials; Benin; Drug Combinations; Female; Humans; Infant, Low Birth Weight; Malaria; Mefloquine; Placenta; Pregnancy; Pregnancy Complications, Parasitic; Pyrimethamine; Stillbirth; Sulfadoxine; Treatment Outcome | 2015 |
Risks of Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficient Infants Exposed to Chlorproguanil-Dapsone, Mefloquine and Sulfadoxine-Pyrimethamine as Part of Intermittent Presumptive Treatment of Malaria in Infants.
Topics: Antimalarials; Cohort Studies; Dapsone; Double-Blind Method; Drug Combinations; Female; Genotype; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydrogenase Deficiency; Hemoglobins; Hemolysis; Humans; Infant; Logistic Models; Malaria; Male; Mefloquine; Multivariate Analysis; Odds Ratio; Poisson Distribution; Polymorphism, Single Nucleotide; Proguanil; Pyrimethamine; Sulfadoxine; Tanzania | 2015 |
Mortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort Study.
Topics: Adult; Africa, Southern; Antimalarials; Child; Child Development; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria; Maternal Exposure; Mefloquine; Morbidity; Pregnancy; Pregnancy Complications, Parasitic; Prenatal Exposure Delayed Effects; Pyrimethamine; Sulfadoxine; Survival Rate; Treatment Outcome | 2016 |
Comparative study of mefloquine and sulphadoxine-pyrimethamine for malaria prevention among pregnant women with HIV in southwest Nigeria.
Topics: Adult; Antimalarials; Drug Combinations; Female; HIV Infections; Humans; Malaria; Mefloquine; Nigeria; Parasitemia; Pregnancy; Pregnancy Complications, Parasitic; Prospective Studies; Pyrimethamine; Sulfadoxine | 2018 |
Counter-Selection of Antimalarial Resistance Polymorphisms by Intermittent Preventive Treatment in Pregnancy.
Topics: Adult; Antimalarials; Drug Combinations; Drug Resistance, Multiple; Female; Humans; Infant, Newborn; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Polymorphism, Genetic; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Outcome; Pyrimethamine; Real-Time Polymerase Chain Reaction; Sulfadoxine | 2020 |
45 other study(ies) available for mefloquine and fanasil, pyrimethamine drug combination
Article | Year |
---|---|
Sensitivity status of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine and sulfadoxine/pyrimethamine in a tribal population of District Sundargarh, Orissa.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; India; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1992 |
[Prevention and treatment of malaria in expatriates living in Black Africa. Influence of chemoresistance. Investigations conducted in Brazzaville (Congo)].
Topics: Adolescent; Adult; Aged; Amodiaquine; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Congo; Drug Combinations; Drug Resistance, Microbial; Europe; Humans; Infant; Infant, Newborn; Malaria; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1991 |
Resistance to antimalarials by Plasmodium falciparum in Arso PIR, Irian Jaya, Indonesia.
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Indonesia; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1991 |
Malaria prophylaxis and self-therapy in airline crews.
Topics: Aerospace Medicine; Africa; Animals; Antimalarials; Culicidae; Drug Combinations; Drug Resistance; Emergencies; Humans; Incidence; Insect Bites and Stings; Malaria; Mefloquine; Patient Compliance; Protective Clothing; Pyrimethamine; Self Medication; Sulfadoxine | 1990 |
Falciparum malaria resistant to quinine and pyrimethamine-sulfadoxine successfully treated with mefloquine.
Topics: Adult; Animals; Antimalarials; Child, Preschool; Drug Combinations; Drug Resistance; Female; Humans; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine; Sulfanilamides | 1990 |
[Uncomplicated malaria attack in an area with high resistance to chloroquine. 3. The use of second-choice oral drug treatment].
Topics: Adolescent; Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Sulfanilamides | 1990 |
Qinghaosu, mefloquine, and pyrimethamine-sulfadoxine in falciparum malaria.
Topics: Antimalarials; Artemisinins; Drug Combinations; Humans; Malaria; Mefloquine; Pyrimethamine; Quinolines; Sesquiterpenes; Sulfadoxine | 1985 |
Qinghaosu, mefloquine, and pyrimethamine-sulfadoxine in falciparum malaria.
Topics: Artemisinins; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Pyrimethamine; Quinolines; Sesquiterpenes; Sulfadoxine; Sulfanilamides | 1985 |
Antagonism of chloroquine with other antimalarials.
Topics: Amodiaquine; Animals; Antimalarials; Artemisinins; Chloroquine; Drug Combinations; Drug Interactions; Drug Resistance; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Sesquiterpenes; Sulfadoxine | 1988 |
Fansimef [Fansidar plus mefloquine] is effective treatment for imported malaria in New Zealand.
Topics: Adolescent; Adult; Animals; Child; Drug Combinations; Female; Humans; Malaria; Male; Mefloquine; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1988 |
Multiple drug resistant Plasmodium falciparum malaria in a pregnant indigenous Zambian woman.
Topics: Adult; Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Erythromycin; Female; Humans; Malaria; Mefloquine; Plasmodium falciparum; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Quinine; Quinolines; Sulfadoxine | 1988 |
Concurrent chloroquine and Fansidar resistance of Plasmodium falciparum: an imported case from Gabon.
Topics: Animals; Chloroquine; Drug Combinations; Drug Resistance; Gabon; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1988 |
[2 cases of multiresistant Plasmodium falciparum malaria contracted in Douala with atypical clinical presentation].
Topics: Adolescent; Adult; Amodiaquine; Animals; Antimalarials; Cameroon; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria; Male; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine | 1987 |
Absence of pharmacokinetic interaction between Fansidar and mefloquine.
Topics: Antimalarials; Drug Combinations; Drug Interactions; Humans; Kinetics; Mefloquine; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1986 |
Chloroquine-resistant falciparum malaria from East Africa.
Topics: Adult; Africa, Eastern; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinine; Quinolines; Sulfadoxine | 1986 |
Single-dose investigation of possible interactions between the components of the antimalarial combination Fansimef.
Topics: Adult; Antimalarials; Biological Availability; Blood Proteins; Drug Combinations; Drug Interactions; Erythrocytes; Half-Life; Humans; Kinetics; Male; Mefloquine; Middle Aged; Protein Binding; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1987 |
[A case of malaria tropicameningoencephalitis (neuromalaria) with chloroquine and pyrimethamine/sulfadoxine resistance].
Topics: Adult; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Male; Mefloquine; Meningoencephalitis; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1985 |
Sensitivity of Plasmodium falciparum to antimalarial drugs in Colombia.
Topics: Amodiaquine; Antimalarials; Chloroquine; Colombia; Drug Combinations; Drug Resistance, Microbial; Geography; Humans; Malaria; Mefloquine; Microbial Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine | 1985 |
[Malaria chemoprophylaxis. Resistance problems].
Topics: Antimalarials; Child; Child, Preschool; Chloroquine; Dapsone; Drug Combinations; Drug Resistance, Microbial; Humans; Infant; Malaria; Mefloquine; Plasmodium falciparum; Proguanil; Pyrimethamine; Quinine; Quinolines; Sulfadoxine | 1985 |
[Malaria and intestinal parasitosis in Indians of the Nadeb-Maku tribe, State of Amazonas, Brazil].
Topics: Adolescent; Adult; Antimalarials; Brazil; Child; Child, Preschool; Drug Combinations; Feces; Female; Humans; Indians, South American; Intestinal Diseases, Parasitic; Malaria; Male; Mefloquine; Middle Aged; Plasmodium falciparum; Pyrimethamine; Quinolines; Sulfadoxine | 1984 |
Highly sensitive and specific determination of mefloquine in biological fluids using gas chromatography mass spectrometry with selected ion monitoring.
Topics: Drug Combinations; Gas Chromatography-Mass Spectrometry; Humans; Mefloquine; Piperidines; Pyrimethamine; Quinolines; Sulfadoxine | 1981 |
Determination of pyrimethamine in human plasma after administration of fansidar of fansidar-mefloquine by means of high-performance liquid chromatography with fluorescence detection.
Topics: Antimalarials; Chromatography, High Pressure Liquid; Drug Combinations; Drug Therapy, Combination; Fluorescence; Half-Life; Humans; Kinetics; Mefloquine; Pyrimethamine; Quinolines; Sulfadoxine; Sulfanilamides | 1982 |
Prevention of malaria in travellers from the United Kingdom.
Topics: Adult; Antimalarials; Developing Countries; Drug Combinations; Female; Humans; Malaria; Male; Mefloquine; Pyrimethamine; Quinine; Sulfadoxine; Travel; United Kingdom | 1993 |
Drug-resistant Plasmodium falciparum malaria in the eastern Transvaal.
Topics: Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1994 |
[In vitro sensitivity of Plasmodium falciparum to mefloquine, quinine, amodiaquine, chloroquine, pyronaridine and sulfadoxine/pyrimethamine in south Yunnan].
Topics: Amodiaquine; Animals; Antimalarials; Chloroquine; Drug Combinations; Drug Resistance; Mefloquine; Naphthyridines; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine | 1994 |
[Current possibilities of malaria chemoprophylaxis].
Topics: Africa; Animals; Antimalarials; Contraindications; Developing Countries; Drug Combinations; Humans; Hungary; Malaria; Mefloquine; Plasmodium falciparum; Pyrimethamine; Sulfadoxine; Travel | 1994 |
Safety of mefloquine and other antimalarial agents in the first trimester of pregnancy.
Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Adverse Drug Reaction Reporting Systems; Antimalarials; Chloroquine; Databases, Factual; Drug Combinations; Drug Industry; Female; Humans; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Parasitic; Pregnancy Trimester, First; Proguanil; Prospective Studies; Pyrimethamine; Risk Factors; Safety; Sulfadoxine; Surveys and Questionnaires | 1998 |
[The proper use of antimalarial drugs currently available].
Topics: Animals; Antimalarials; Chemoprevention; Chloroquine; Contraindications; Drug Combinations; Drug Resistance; Endemic Diseases; Humans; Malaria; Malaria, Falciparum; Malaria, Vivax; Mefloquine; Phenanthrenes; Plasmodium; Plasmodium falciparum; Plasmodium malariae; Plasmodium vivax; Proguanil; Pyrimethamine; Quinine; Sulfadoxine; Travel | 1998 |
An unusual case of multidrug-resistant Plasmodium vivax malaria in Mumbai (Bombay), India.
Topics: Adolescent; Animals; Antimalarials; Artemether; Artemisinins; Chloroquine; Drug Combinations; Drug Resistance, Multiple; Humans; India; Malaria, Vivax; Male; Mefloquine; Plasmodium vivax; Primaquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine | 2000 |
Treatment of uncomplicated Plasmodium falciparum malaria in Myanmar: a clinical decision analysis.
Topics: Antimalarials; Chloroquine; Cost-Benefit Analysis; Decision Support Techniques; Decision Trees; Drug Combinations; Humans; Malaria, Falciparum; Mefloquine; Myanmar; Pyrimethamine; Sulfadoxine; Treatment Failure; Treatment Outcome | 2000 |
[Blackwater fever].
Topics: Adolescent; Adult; Aged; Antimalarials; Atovaquone; Blackwater Fever; Critical Care; Diagnosis, Differential; Drug Combinations; Humans; Mefloquine; Middle Aged; Naphthoquinones; Phenanthrenes; Prognosis; Proguanil; Pyrimethamine; Quinine; Sulfadoxine | 2002 |
Descriptive study on the efficacy and safety of artesunate suppository in combination with other antimalarials in the treatment of severe malaria in Sudan.
Topics: Administration, Rectal; Adolescent; Adult; Aged; Antimalarials; Artemisinins; Artesunate; Doxycycline; Drug Combinations; Drug Therapy, Combination; Female; Humans; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Pyrimethamine; Sesquiterpenes; Severity of Illness Index; Sudan; Sulfadoxine; Treatment Outcome | 2003 |
Malaria in Austria 1990-2000.
Topics: Adolescent; Adult; Age Distribution; Animals; Austria; Chemoprevention; Child; Child, Preschool; Chloroquine; Disease Notification; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Malaria; Malaria, Falciparum; Malaria, Vivax; Male; Mefloquine; Patient Compliance; Plasmodium falciparum; Plasmodium malariae; Plasmodium vivax; Proguanil; Pyrimethamine; Sex Distribution; Sulfadoxine | 2003 |
Asymptomatic, recrudescent, chloroquine-resistant Plasmodium falciparum infections in Nigerian children: clinical and parasitological characteristics and implications for the transmission of drug-resistant parasites.
Topics: Animals; Antimalarials; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria, Falciparum; Male; Mefloquine; Nigeria; Plasmodium falciparum; Prevalence; Pyrimethamine; Recurrence; Statistics as Topic; Sulfadoxine; Treatment Failure | 2003 |
Diagnosis and treatment of malaria in children.
Topics: Animals; Antimalarials; Atovaquone; Child; Chloroquine; Drug Combinations; Humans; Malaria; Malaria, Falciparum; Mefloquine; Naphthoquinones; Plasmodium falciparum; Proguanil; Pyrimethamine; Sulfadoxine | 2003 |
Artesunate combinations for malaria.
Topics: Antimalarials; Artemisinins; Artesunate; Cost-Benefit Analysis; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Humans; Malaria; Mefloquine; Pyrimethamine; Sesquiterpenes; Sulfadoxine; Treatment Outcome | 2004 |
Mefloquine--its 20 years in the Thai Malaria Control Program.
Topics: Animals; Antimalarials; Communicable Disease Control; Contraindications; Drug Combinations; Drug Resistance; Humans; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Program Evaluation; Pyrimethamine; Sulfadoxine; Thailand | 2004 |
Mode of action and choice of antimalarial drugs for intermittent preventive treatment in infants.
Topics: Amodiaquine; Antimalarials; Clinical Trials as Topic; Drug Combinations; Drug Resistance; Female; Humans; Infant; Malaria; Male; Mefloquine; Pyrimethamine; Sulfadoxine | 2009 |
Anti-bacterial activity of intermittent preventive treatment of malaria in pregnancy: comparative in vitro study of sulphadoxine-pyrimethamine, mefloquine, and azithromycin.
Topics: Anti-Bacterial Agents; Antimalarials; Azithromycin; Bacterial Infections; Drug Combinations; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mefloquine; Microbial Sensitivity Tests; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Sulfadoxine | 2010 |
Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin.
Topics: Adult; Antimalarials; Benin; Biomarkers; Chemoprevention; Clinical Trials as Topic; Dihydropteroate Synthase; Drug Combinations; Drug Resistance; Female; Gene Dosage; Genotype; Humans; Malaria, Falciparum; Mefloquine; Multidrug Resistance-Associated Proteins; Mutation, Missense; Plasmodium falciparum; Pregnancy; Pregnancy Complications; Pyrimethamine; Sulfadoxine; Tetrahydrofolate Dehydrogenase | 2011 |
Distribution of drug resistance genotypes in Plasmodium falciparum in an area of limited parasite diversity in Saudi Arabia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimalarials; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Combinations; Drug Resistance; Female; Genotype; Humans; Infant; Male; Mefloquine; Membrane Transport Proteins; Middle Aged; Multidrug Resistance-Associated Proteins; Mutation; Phenanthrenes; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Saudi Arabia; Sulfadoxine; Tetrahydrofolate Dehydrogenase; Young Adult | 2012 |
Plasmodium falciparum Polymorphisms associated with ex vivo drug susceptibility and clinical effectiveness of artemisinin-based combination therapies in Benin.
Topics: Amodiaquine; Antimalarials; Artemisinins; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Inhibitory Concentration 50; Lumefantrine; Male; Mefloquine; Membrane Transport Proteins; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins; Pyrimethamine; Quinine; Sulfadoxine | 2014 |
Evaluation of intermittent preventive treatment of malaria against group B Streptococcus colonization in pregnant women: a nested analysis of a randomized controlled clinical trial of sulfadoxine/pyrimethamine versus mefloquine.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antimalarials; Drug Combinations; Female; Gabon; Humans; Malaria; Mefloquine; Pregnancy; Pregnancy Complications, Infectious; Pyrimethamine; Randomized Controlled Trials as Topic; Rectum; Streptococcal Infections; Streptococcus agalactiae; Sulfadoxine; Vagina; Young Adult | 2015 |
Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patients.
Topics: Adolescent; Adult; Anorexia; Antimalarials; Artemisinins; Artesunate; Child; Child, Preschool; Dizziness; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Host-Parasite Interactions; Humans; Malaria; Male; Mefloquine; Nausea; Outcome Assessment, Health Care; Plasmodium falciparum; Plasmodium vivax; Psychotic Disorders; Pyrimethamine; Sulfadoxine; Thailand; Vomiting; Young Adult | 2017 |
Population Pharmacokinetics of Mefloquine Intermittent Preventive Treatment for Malaria in Pregnancy in Gabon.
Topics: Adolescent; Adult; Antimalarials; Drug Combinations; Female; Humans; Malaria; Mefloquine; Pharmacokinetics; Plasmodium falciparum; Pregnancy; Pyrimethamine; Sulfadoxine; Young Adult | 2019 |